MedPath

Monteplase

Generic Name
Monteplase
Drug Type
Biotech
CAS Number
156616-23-8
Unique Ingredient Identifier
0J4C69C6FB

Overview

Monteplase has been used in trials studying the treatment of Pulmonary Embolism.

Background

Monteplase has been used in trials studying the treatment of Pulmonary Embolism.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath